These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37542902)

  • 1. Polysarcosine-Coated liposomes attenuating immune response induction and prolonging blood circulation.
    Hu M; Taguchi K; Matsumoto K; Kobatake E; Ito Y; Ueda M
    J Colloid Interface Sci; 2023 Dec; 651():273-283. PubMed ID: 37542902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evasion of the accelerated blood clearance phenomenon by polysarcosine coating of liposomes.
    Son K; Ueda M; Taguchi K; Maruyama T; Takeoka S; Ito Y
    J Control Release; 2020 Jun; 322():209-216. PubMed ID: 32194174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysarcosine-based lipid formulations for intracranial delivery of mRNA.
    Bi D; Unthan DM; Hu L; Bussmann J; Remaut K; Barz M; Zhang H
    J Control Release; 2023 Apr; 356():1-13. PubMed ID: 36803765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time Interval of Two Injections and First-Dose Dependent of Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomal Gambogenic Acid: The Contribution of PEG-Specific IgM.
    Wang F; Ye X; Wu Y; Wang H; Sheng C; Peng D; Chen W
    J Pharm Sci; 2019 Jan; 108(1):641-651. PubMed ID: 30595169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes.
    Kierstead PH; Okochi H; Venditto VJ; Chuong TC; Kivimae S; Fréchet JMJ; Szoka FC
    J Control Release; 2015 Sep; 213():1-9. PubMed ID: 26093095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
    Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes.
    Ishida T; Ichihara M; Wang X; Kiwada H
    J Control Release; 2006 Oct; 115(3):243-50. PubMed ID: 17011060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes.
    Shimizu T; Abu Lila AS; Fujita R; Awata M; Kawanishi M; Hashimoto Y; Okuhira K; Ishima Y; Ishida T
    Eur J Pharm Biopharm; 2018 Jun; 127():142-149. PubMed ID: 29462689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rg3 endows liposomes with prolonged blood circulation and reduced accelerated blood clearance.
    Xia J; Chen C; Dong M; Zhu Y; Wang A; Li S; Zhang R; Feng C; Jiang X; Xu X; Wang J
    J Control Release; 2023 Dec; 364():23-36. PubMed ID: 37863358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A higher dose of PEGylated gold nanoparticles reduces the accelerated blood clearance phenomenon effect and induces spleen B lymphocytes in albino mice.
    Abu-Dief AM; Alsehli M; Awaad A
    Histochem Cell Biol; 2022 Jun; 157(6):641-656. PubMed ID: 35157114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
    Abu Lila AS; Uehara Y; Ishida T; Kiwada H
    J Pharm Sci; 2014 Feb; 103(2):557-66. PubMed ID: 24347396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes.
    Ishida T; Harada M; Wang XY; Ichihara M; Irimura K; Kiwada H
    J Control Release; 2005 Jul; 105(3):305-17. PubMed ID: 15908032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Repeated Injections of Adenosine Diphosphate-Encapsulated Liposomes Coated with a Fibrinogen γ-Chain Dodecapeptide Developed as a Synthetic Platelet Substitute on Accelerated Blood Clearance in a Healthy and an Anticancer Drug-Induced Thrombocytopenia Rat Model.
    Taguchi K; Hashimoto M; Ogaki S; Watanabe H; Takeoka S; Ikeda Y; Handa M; Otagiri M; Maruyama T
    J Pharm Sci; 2015 Sep; 104(9):3084-91. PubMed ID: 25755009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated blood clearance of pegylated liposomal topotecan: influence of polyethylene glycol grafting density and animal species.
    Li C; Cao J; Wang Y; Zhao X; Deng C; Wei N; Yang J; Cui J
    J Pharm Sci; 2012 Oct; 101(10):3864-76. PubMed ID: 22777607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Accelerated blood clearance (ABC) phenomenon induced by administration of PEGylated liposome].
    Ishida T; Kiwada H
    Yakugaku Zasshi; 2008 Feb; 128(2):233-43. PubMed ID: 18239370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon.
    Shiraishi K; Hamano M; Ma H; Kawano K; Maitani Y; Aoshi T; Ishii KJ; Yokoyama M
    J Control Release; 2013 Feb; 165(3):183-90. PubMed ID: 23220106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: Appearance of an unexplained mechanism in the ABC phenomenon.
    El Sayed MM; Takata H; Shimizu T; Kawaguchi Y; Abu Lila AS; Elsadek NE; Alaaeldin E; Ishima Y; Ando H; Kamal A; Sarhan HA; Ishida T
    J Control Release; 2020 Jul; 323():102-109. PubMed ID: 32278827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon.
    Shimizu T; Ishida T; Kiwada H
    Immunobiology; 2013 May; 218(5):725-32. PubMed ID: 22995937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes.
    Tagami T; Nakamura K; Shimizu T; Yamazaki N; Ishida T; Kiwada H
    J Control Release; 2010 Mar; 142(2):160-6. PubMed ID: 19850094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy.
    Yang Q; Ma Y; Zhao Y; She Z; Wang L; Li J; Wang C; Deng Y
    Int J Nanomedicine; 2013; 8():1257-68. PubMed ID: 23576868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.